Klox Technologies Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Klox Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014258
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Klox Technologies Inc (Klox Technologies) is a specialty pharmaceutical company, which focuses on the development and commercialization of a proprietary BioPhotonic technology platform. Its pipeline portfolio includes non-invasive wound care treatment solutions, dermatological treatment solutions and adjunct treatment to scaling and root planning. The company’s technology platform is a non-invasive, pathology-specific topical treatment platform which uses the power of light and photo-activated, oxygen-rich gel formulations to treat a wide range of skin and soft tissue disorders. The company carries out research in dermatology, wound care, oral care and cosmetology. The company has collaborations with LEO Pharma A/S to commercialize its technology platform in the field of dermatology. The company has operational presence in Canada and Italy. Klox Technologies is headquartered in Laval, Quebec, Canada.

Klox Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Klox Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Klox Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 9
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Leo Pharma Enters into Licensing Agreement with Klox Technologies 11
Klox Technologies Enters Into Licensing Agreement With Sandoz Canada 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
Licensing Agreements 14
Colgate-Palmolive Enters into Licensing Agreement with Klox Technologies 14
Equity Offering 15
Klox Technologies Withdraws IPO 15
Klox Technologies Inc – Key Competitors 16
Klox Technologies Inc – Key Employees 17
Klox Technologies Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Klox Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Klox Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Klox Technologies Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Klox Technologies Inc, Medical Devices Deals, 2011 to YTD 2017 9
Klox Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Leo Pharma Enters into Licensing Agreement with Klox Technologies 11
Klox Technologies Enters Into Licensing Agreement With Sandoz Canada 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
Colgate-Palmolive Enters into Licensing Agreement with Klox Technologies 14
Klox Technologies Withdraws IPO 15
Klox Technologies Inc, Key Competitors 16
Klox Technologies Inc, Key Employees 17
Klox Technologies Inc, Other Locations 18

★海外企業調査レポート[Klox Technologies Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dermira Inc (DERM):企業の財務・戦略的SWOT分析
    Summary Dermira Inc (Dermira) is a biopharmaceutical company that identifies, develops and commercializes therapeutic solutions for the treatment of dermatologic diseases, such as hyperhidrosis, acne vulgaris and atopic dermatitis. The company’s product includes QBREXZA (glycopyrronium) cloth, an an …
  • Energizer Holdings, Inc.:戦略・SWOT・企業財務分析
    Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Energizer Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sumitomo Rubber Industries Ltd (5110):企業の財務・戦略的SWOT分析
    Sumitomo Rubber Industries Ltd (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Alliance Healthcare Services Inc (AIQ)-製薬・医療分野:企業M&A・提携分析
    Summary Alliance Healthcare Services Inc (Alliance Healthcare Services) is a provider of outsourced services including diagnostic imaging services. It provides a full line of services ranging from systems, technologists to operate the systems, sales and marketing, patient scheduling and pre-authoriz …
  • China National Chemical Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Chemical Corp (ChemChina) is a state-owned enterprise that develops and markets chemicals. The company offers chemical materials and specialty chemicals, agrochemicals, oil processing and refining products, basic chemicals, and rubber products. ChemChina also manufactures equi …
  • Assore Limited:企業の戦略・SWOT・財務分析
    Assore Limited - Strategy, SWOT and Corporate Finance Report Summary Assore Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Theralase Technologies Inc (TLT):製品パイプライン分析
    Summary Theralase Technologies Inc (Theralase) is a medical equipment company that designs, develops and manufactures laser and laser technology for human, companion animal and equine applications. The company offers products such as controller, multiple probe, triple probe, single probe, multiple p …
  • Glycotope GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Glycotope GmbH (Glycotope) is a biopharmaceutical company that develops immuno-oncology products for the treatment of various types of cancer. The company’s expression platform offers proprietary technologies such as Glycobody (GET) and GlycoExpress(GEX) that allows the glycosylation of anti …
  • Meritage Homes Corporation:企業の戦略・SWOT・財務情報
    Meritage Homes Corporation - Strategy, SWOT and Corporate Finance Report Summary Meritage Homes Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Revance Therapeutics Inc (RVNC)-製薬・医療分野:企業M&A・提携分析
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Neuralstem Inc (CUR):企業の財務・戦略的SWOT分析
    Summary Neuralstem Inc (Neuralstem) is a biopharmaceutical company that develops novel treatments for nervous system diseases. The company offers cell therapy treatment for ALS, ischemic stroke, spinal cord injury, multiple sclerosis, optic neuritis, Alzheimer’s disease, traumatic brain injury, peri …
  • Seattle Genetics Inc (SGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Seattle Genetics Inc (Seattle Genetics) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. The company's lead product Adcetris (brentuximab vedotin) is an antibody-drug conjugate indicated for the treatment of relapsed …
  • Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Exco Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Exco Resources Inc (Exco Resources) is an oil and gas company that offers crude oil and natural gas. The company offers acquisition, exploration, development, exploitation, operations, management, …
  • Veryan Medical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Veryan Medical Ltd (Veryan), a subsidiary of Veryan Holdings Ltd, is a medical device company that designs and develops vascular biomimetic stents. It develops BioMimics 3D stent, a peripheral self-expanding nickel-titanium alloy (Nitinol) stent with unique three-dimensional helical centreli …
  • Alembic Pharmaceuticals Ltd (APLLTD):製薬・医療:M&Aディール及び事業提携情報
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antib …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • PDL BioPharma Inc:企業の戦略的SWOT分析
    PDL BioPharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Savanna Energy Services Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Savanna Energy Services Corp (Savanna), a subsidiary of Total Energy Services Inc, is an oilfield service provider that offers drilling, well servicing and oilfield rental services. The company conducts drilling, hybrid drilling, and well servicing and oilfield services such as oilfield equi …
  • Iamgold Corporation:企業のM&A・事業提携・投資動向
    Iamgold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iamgold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Banco Occidental de Descuento:企業の戦略・SWOT・財務情報
    Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report Summary Banco Occidental de Descuento - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆